Ultramicrosize Griseofulvin Tablet
Product Images NDC 42794-014

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ultramicrosize Griseofulvin (NDC 42794-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sigmapharm Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

125 mg Container Label-30 Fill (Mm2)

This is a description of a medication with NDC number 42794-013-08 indicated for the treatment of ringworm infections. The medication is in tablet form with each tablet containing 125 mg of griseofulvin ultramicrosize crystals. It is to be taken as directed by a physician and kept in a tightly sealed container at room temperature. The medication should be kept out of reach of children.*

FDA Label Image

Image Description (Mm3)

This text contains information about a medication with the NDC code 42794-014-08. The tablets contain ultramicrosize crystals of griseofulvin and each tablet has 250 mg of the medication. Dosage and administration instructions can be found in the package insert. The tablets should be stored in a tight and light-resistant container at 20-25°C. The medication is only available through prescription and must be kept out of reach of children. The manufacturer is Sigmapharm Laboratories, LLC.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.